Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS.

Myxovirus resistance protein A mRNA is related to clinical exacerbations, the number of contrast-enhancing lesions in MRI and may be useful as a marker
Enhanced by Zemanta

No comments: